Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
Explainer-Why are hepatitis B vaccines given to newborns?- The 15 Most Compelling Books in History
- Figure out How to Modify Your Pre-assembled Home for Greatest Solace and Stylish Allure
- An Aide On Upgrading Your FICO rating
- Pick Your Top Method for starting the Morning
- Telecommute Arrangement: What's Pivotal for Your Efficiency?
- Israel halts defense sales to France, citing 'hostile attitude,' sources tell 'Post'
- Crew-11 astronauts undock in 1st-ever medical evacuation from the International Space Station (video)
- Hot Electric Vehicles for 2023
